# MAGNACHIP SEMICONDUCTOR Corp: financial statements, quarterly

MX · NYSE · CIK 1325702 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mx.md) · [Financials](/companies/mx/financials.md) · [Filings](/companies/mx/filings.md) · [Insiders](/companies/mx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [61.2](/filings/0001193125-24-253153.md) | [50.8 d](/filings/0001193125-25-054851.md) | [43.4](/filings/0001193125-25-117840.md) | [46.4](/filings/0001193125-25-173550.md) | [55.4](/filings/0001193125-25-274333.md) | [51.2 d](/filings/0001193125-26-108435.md) | [44.7](/filings/0001193125-26-214750.md) | [47.6](/filings/0001193125-26-342416.md) | [45.9](/filings/0001193125-25-274333.md) | [40.6 d](/filings/0001193125-26-108435.md) | [46.2](/filings/0001193125-26-214750.md) | [44.7](/filings/0001193125-26-342416.md) |
| Cost of revenue | $m | [46.8](/filings/0001193125-24-253153.md) | [39.3 d](/filings/0001193125-25-054851.md) | [37.1](/filings/0001193125-25-117840.md) | [36.6](/filings/0001193125-25-173550.md) | [43.9](/filings/0001193125-25-274333.md) | [40.1 d](/filings/0001193125-26-108435.md) | [35.4](/filings/0001193125-26-214750.md) | [37.9](/filings/0001193125-26-342416.md) | [37.4](/filings/0001193125-25-274333.md) | [36.8 d](/filings/0001193125-26-108435.md) | [39.0](/filings/0001193125-26-214750.md) | [36.1](/filings/0001193125-26-342416.md) |
| Gross profit | $m | [14.5](/filings/0001193125-24-253153.md) | [11.5 d](/filings/0001193125-25-054851.md) | [6.4](/filings/0001193125-25-117840.md) | [9.8](/filings/0001193125-25-173550.md) | [11.5](/filings/0001193125-25-274333.md) | [11.1 d](/filings/0001193125-26-108435.md) | [9.4](/filings/0001193125-26-214750.md) | [9.7](/filings/0001193125-26-342416.md) | [8.5](/filings/0001193125-25-274333.md) | [3.8 d](/filings/0001193125-26-108435.md) | [7.2](/filings/0001193125-26-214750.md) | [8.6](/filings/0001193125-26-342416.md) |
| Research and development | $m | [11.6](/filings/0001193125-24-253153.md) | [15.4 d](/filings/0001193125-25-054851.md) | [6.2](/filings/0001193125-25-117840.md) | [5.8](/filings/0001193125-25-173550.md) | [6.5](/filings/0001193125-25-274333.md) | [6.6 d](/filings/0001193125-26-108435.md) | [5.4](/filings/0001193125-26-214750.md) | [6.5](/filings/0001193125-26-342416.md) | [7.8](/filings/0001193125-25-274333.md) | [7.6 d](/filings/0001193125-26-108435.md) | [6.7](/filings/0001193125-26-214750.md) | [7.9](/filings/0001193125-26-342416.md) |
| Selling, general and administrative | $m | [12.1](/filings/0001193125-24-253153.md) | [12.1 d](/filings/0001193125-25-054851.md) | [9.5](/filings/0001193125-25-117840.md) | [9.7](/filings/0001193125-25-173550.md) | [9.5](/filings/0001193125-25-274333.md) | [9.8 d](/filings/0001193125-26-108435.md) | [9.2](/filings/0001193125-26-214750.md) | [9.0](/filings/0001193125-26-342416.md) | [8.3](/filings/0001193125-25-274333.md) | [8.6 d](/filings/0001193125-26-108435.md) | [7.7](/filings/0001193125-26-214750.md) | [8.7](/filings/0001193125-26-342416.md) |
| Operating income | $m | [(9.2)](/filings/0001193125-24-253153.md) | [(15.9) d](/filings/0001193125-25-054851.md) | [(9.4)](/filings/0001193125-25-117840.md) | [(5.7)](/filings/0001193125-25-173550.md) | [(4.5)](/filings/0001193125-25-274333.md) | [(6.8) d](/filings/0001193125-26-108435.md) | [(5.3)](/filings/0001193125-26-214750.md) | [(6.6)](/filings/0001193125-26-342416.md) | [(11.5)](/filings/0001193125-25-274333.md) | [(12.4) d](/filings/0001193125-26-108435.md) | [(7.2)](/filings/0001193125-26-214750.md) | [(10.0)](/filings/0001193125-26-342416.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(4.4)](/filings/0001193125-24-253153.md) | [(2.4) d](/filings/0001193125-25-054851.md) | [1.9](/filings/0001193125-25-117840.md) | [(5.4)](/filings/0001193125-25-173550.md) | [6.1](/filings/0001193125-25-274333.md) | [(10.5) d](/filings/0001193125-26-108435.md) | [(0.4)](/filings/0001193125-26-214750.md) | [(4.1)](/filings/0001193125-26-342416.md) | [(4.2)](/filings/0001193125-25-274333.md) | [(9.2) d](/filings/0001193125-26-108435.md) | [(1.9)](/filings/0001193125-26-214750.md) | [(2.0)](/filings/0001193125-26-342416.md) |
| Net income | $m | [(5.2)](/filings/0001193125-24-253153.md) | [(6.0) d](/filings/0001193125-25-054851.md) | [(15.4)](/filings/0001193125-25-117840.md) | [(13.0)](/filings/0001193125-25-173550.md) | [(9.6)](/filings/0001193125-25-274333.md) | [(16.3) d](/filings/0001193125-26-108435.md) | [(8.9)](/filings/0001193125-26-214750.md) | [0.3](/filings/0001193125-26-342416.md) | [(13.1)](/filings/0001193125-25-274333.md) | [(8.1) d](/filings/0001193125-26-108435.md) | [(4.6)](/filings/0001193125-26-214750.md) | [(4.8)](/filings/0001193125-26-342416.md) |
| Diluted EPS | $ per share | [(0.13)](/filings/0001193125-24-253153.md) | not reported | [(0.40)](/filings/0001193125-25-117840.md) | [(0.34)](/filings/0001193125-25-173550.md) | [(0.26)](/filings/0001193125-25-274333.md) | not reported | [(0.24)](/filings/0001193125-26-214750.md) | [0.01](/filings/0001193125-26-342416.md) | [(0.36)](/filings/0001193125-25-274333.md) | not reported | [(0.13)](/filings/0001193125-26-214750.md) | [(0.13)](/filings/0001193125-26-342416.md) |
| Basic EPS | $ per share | [(0.13)](/filings/0001193125-24-253153.md) | not reported | [(0.40)](/filings/0001193125-25-117840.md) | [(0.34)](/filings/0001193125-25-173550.md) | [(0.26)](/filings/0001193125-25-274333.md) | not reported | [(0.24)](/filings/0001193125-26-214750.md) | [0.01](/filings/0001193125-26-342416.md) | [(0.36)](/filings/0001193125-25-274333.md) | not reported | [(0.13)](/filings/0001193125-26-214750.md) | [(0.13)](/filings/0001193125-26-342416.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [167](/filings/0001193125-23-273533.md) | [158](/filings/0001193125-25-054851.md) | [172](/filings/0001193125-24-136202.md) | [132](/filings/0001193125-24-196988.md) | [121](/filings/0001193125-24-253153.md) | [139](/filings/0001193125-26-108435.md) | [133](/filings/0001193125-25-117840.md) | [113](/filings/0001193125-25-173550.md) | [108](/filings/0001193125-25-274333.md) | [104](/filings/0001193125-26-342416.md) | [94.6](/filings/0001193125-26-214750.md) | [87.9](/filings/0001193125-26-342416.md) |
| Current assets | $m | [278](/filings/0001193125-23-273533.md) | [245](/filings/0001193125-25-054851.md) | [258](/filings/0001193125-24-136202.md) | [254](/filings/0001193125-24-196988.md) | [242](/filings/0001193125-24-253153.md) | [219](/filings/0001193125-26-108435.md) | [215](/filings/0001193125-25-117840.md) | [199](/filings/0001193125-25-173550.md) | [197](/filings/0001193125-25-274333.md) | [177](/filings/0001193125-26-342416.md) | [170](/filings/0001193125-26-214750.md) | [164](/filings/0001193125-26-342416.md) |
| Total assets | $m | [434](/filings/0001193125-23-273533.md) | [420](/filings/0001193125-25-054851.md) | [426](/filings/0001193125-24-136202.md) | [413](/filings/0001193125-24-196988.md) | [411](/filings/0001193125-24-253153.md) | [379](/filings/0001193125-26-108435.md) | [374](/filings/0001193125-25-117840.md) | [371](/filings/0001193125-25-173550.md) | [360](/filings/0001193125-25-274333.md) | [352](/filings/0001193125-26-342416.md) | [335](/filings/0001193125-26-214750.md) | [325](/filings/0001193125-26-342416.md) |
| Current liabilities | $m | [47.4](/filings/0001193125-23-273533.md) | [46.9](/filings/0001193125-25-054851.md) | [44.9](/filings/0001193125-24-136202.md) | [50.6](/filings/0001193125-24-196988.md) | [50.3](/filings/0001193125-24-253153.md) | [46.3](/filings/0001193125-26-108435.md) | [47.8](/filings/0001193125-25-117840.md) | [42.9](/filings/0001193125-25-173550.md) | [45.7](/filings/0001193125-25-274333.md) | [43.4](/filings/0001193125-26-342416.md) | [71.7](/filings/0001193125-26-214750.md) | [67.7](/filings/0001193125-26-342416.md) |
| Total liabilities | $m | [80.6](/filings/0001193125-23-273533.md) | [75.9](/filings/0001193125-25-054851.md) | [104](/filings/0001193125-24-136202.md) | [107](/filings/0001193125-24-196988.md) | [112](/filings/0001193125-24-253153.md) | [103](/filings/0001193125-26-108435.md) | [105](/filings/0001193125-25-117840.md) | [100](/filings/0001193125-25-173550.md) | [104](/filings/0001193125-25-274333.md) | [103](/filings/0001193125-26-342416.md) | [103](/filings/0001193125-26-214750.md) | [98.3](/filings/0001193125-26-342416.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001193125-25-054851.md) | [29.7](/filings/0001193125-24-136202.md) | [28.8](/filings/0001193125-24-196988.md) | [30.3](/filings/0001193125-24-253153.md) | [27.2](/filings/0001193125-26-108435.md) | [27.3](/filings/0001193125-25-117840.md) | [36.5](/filings/0001193125-25-173550.md) | [38.9](/filings/0001193125-25-274333.md) | [44.6](/filings/0001193125-26-342416.md) | [15.9](/filings/0001193125-26-214750.md) | [15.6](/filings/0001193125-26-342416.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-342416.md) | [26.4](/filings/0001193125-26-214750.md) | [25.9](/filings/0001193125-26-342416.md) |
| Shareholders' equity | $m | [354](/filings/0001193125-24-253153.md) | [345](/filings/0001193125-26-108435.md) | [322](/filings/0001193125-25-173550.md) | [306](/filings/0001193125-25-274333.md) | [300](/filings/0001193125-25-274333.md) | [277](/filings/0001193125-26-342416.md) | [269](/filings/0001193125-26-342416.md) | [270](/filings/0001193125-26-342416.md) | [255](/filings/0001193125-25-274333.md) | [248](/filings/0001193125-26-342416.md) | [233](/filings/0001193125-26-342416.md) | [227](/filings/0001193125-26-342416.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.7 d](/filings/0001193125-24-253153.md) | [(2.8) d](/filings/0001193125-25-054851.md) | [(4.0)](/filings/0001193125-25-117840.md) | [(1.1) d](/filings/0001193125-25-173550.md) | [(12.9) d](/filings/0001193125-25-274333.md) | [11.9 d](/filings/0001193125-26-108435.md) | [(0.0)](/filings/0001193125-26-214750.md) | [(0.0) d](/filings/0001193125-26-342416.md) | [(29.6) d](/filings/0001193125-25-274333.md) | [5.4 d](/filings/0001193125-26-108435.md) | [0.0](/filings/0001193125-26-214750.md) | [(0.0) d](/filings/0001193125-26-342416.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001193125-24-253153.md) | [4.7 d](/filings/0001193125-25-054851.md) | [0.7](/filings/0001193125-25-117840.md) | [0.9 d](/filings/0001193125-25-173550.md) | [2.6 d](/filings/0001193125-25-274333.md) | [7.4 d](/filings/0001193125-26-108435.md) | [0.0](/filings/0001193125-26-214750.md) | [0.0 d](/filings/0001193125-26-342416.md) | [19.7 d](/filings/0001193125-25-274333.md) | [10.3 d](/filings/0001193125-26-108435.md) | [0.0](/filings/0001193125-26-214750.md) | [0.0 d](/filings/0001193125-26-342416.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [6.2 d](/filings/0001193125-24-253153.md) | [8.7 d](/filings/0001193125-25-054851.md) | [4.7](/filings/0001193125-25-117840.md) | [2.2 d](/filings/0001193125-25-173550.md) | [2.6 d](/filings/0001193125-25-274333.md) | [3.4 d](/filings/0001193125-26-108435.md) | [0.0](/filings/0001193125-26-214750.md) | [0.0 d](/filings/0001193125-26-342416.md) | [4.3 d](/filings/0001193125-25-274333.md) | [0.0 d](/filings/0001193125-26-108435.md) | [0.0](/filings/0001193125-26-214750.md) | [0.0 d](/filings/0001193125-26-342416.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.9](/filings/0001193125-23-273533.md) | [43.4](/filings/0001193125-24-136202.md) | [41.7](/filings/0001193125-24-196988.md) | [40.1](/filings/0001193125-24-253153.md) | [38.5](/filings/0001193125-25-117840.md) | [38.2](/filings/0001193125-25-173550.md) | [37.5](/filings/0001193125-25-274333.md) | [36.9](/filings/0001193125-26-214750.md) | [36.8](/filings/0001193125-26-342416.md) | [35.9](/filings/0001193125-25-274333.md) | [36.4](/filings/0001193125-26-214750.md) | [36.5](/filings/0001193125-26-342416.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,510,111 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342416.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.